A powerful drug derived from marijuana just got a major green light on its way to FDA approval
- An experimental cannabis-derived drug has gotten a unanimous approval vote from a group of scientists convened by the Food and Drug Administration.
- The committee concluded that the drug, called Epidiolex, is safe and effective.
- That vote will play a key role in the FDA's final approval decision, which is expected in June.
- Epidiolex is made by GW Pharmaceuticals and is designed to treat two rare forms of epilepsy using cannabidiol, or CBD.
GW Pharma's long road to FDA approval
The FDA vote and the future of cannabis-derived drugs
Published April 19, 2018
Join the discussion — please keep to our Community Guidelines.